Exovate 0.05% contains Clobetasol Propionate, a super-high potency topical corticosteroid classified under Other Topical Corticosteroids. It is intended for short-term treatment of severe inflammatory and hyperkeratotic skin disorders that do not respond adequately to less potent topical steroids. Exovate 0.05% provides rapid relief from inflammation, itching, redness, and thickened skin when used under proper medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Exovate 0.05% is indicated for adults, elderly patients, and children over 1 year of age in the management of the following dermatoses:

• Psoriasis (excluding widespread plaque psoriasis)

• Recalcitrant dermatoses

• Lichen planus

• Discoid lupus erythematosus

• Other corticosteroid-responsive skin conditions that fail to respond satisfactorily to less potent steroids

Pharmacology

Clobetasol Propionate is a very potent topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Its anti-inflammatory effect is mediated through multiple mechanisms, including inhibition of late-phase allergic reactions. It reduces mast cell density, suppresses chemotaxis and activation of eosinophils, decreases cytokine production, and inhibits arachidonic acid metabolism, resulting in significant reduction of inflammation and pruritus.

Dosage

Cream and Ointment

• Adults, elderly, and children over 1 year:

  • Apply a thin layer to affected areas twice daily and rub in gently

  • Treatment duration should not exceed 2 consecutive weeks

  • Maximum dose: 50 g per week

  • In children, treatment should preferably be limited to 5 days and reviewed weekly

• In resistant lesions, short-term occlusion with polythene film may be used if necessary

Scalp Solution

• Apply once or twice daily to affected scalp areas and rub in gently

• Maximum weekly dose: 50 ml

• Discontinue if no response is seen within one week or once the lesion heals

• Use for brief periods only

Topical Spray

• Apply twice daily directly to affected skin and rub in gently

• Maximum weekly dose: 50 g (59 ml)

• Do not exceed 26 sprays per application or 52 sprays per day

• Treatment duration should not exceed 4 weeks

• Use beyond 2 weeks only for localized moderate to severe plaque psoriasis

• Use in patients under 18 years is not recommended

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Administration

• Route of administration: Cutaneous use only

• Creams are suitable for moist or weeping lesions

• Ointments are suitable for dry, thickened, or scaly lesions

Drug Interactions

Drugs that inhibit CYP3A4 (such as ritonavir or itraconazole) may reduce corticosteroid metabolism, increasing systemic exposure and the risk of adverse effects.

Contraindications

Exovate 0.05% is contraindicated in patients with:

• Hypersensitivity to Clobetasol Propionate or any formulation component

• Rosacea

• Acne vulgaris

• Perioral dermatitis

• Perianal or genital pruritus

• Pruritus without inflammation

• Untreated cutaneous infections

Side Effects

Commonly reported adverse effects include:

• Burning sensation

• Stinging

Less frequent reactions include itching, skin atrophy, cracking, and fissuring. Prolonged or excessive use may lead to systemic absorption and rare cases of Cushing’s syndrome, particularly in infants and adults.

Pregnancy and Lactation

Data on use during pregnancy are limited. Animal studies have shown fetal abnormalities with topical corticosteroids, though relevance to humans is unclear. Exovate 0.05% should be used during pregnancy and lactation only if the expected benefit outweighs potential risks. Caution is advised when used in nursing mothers, as excretion in human milk is unknown.

Precautions and Warnings

• Clean skin before applying fresh occlusive dressings

• Use cautiously in psoriasis due to risk of rebound relapse

• Facial use should be limited to 5 days

• Avoid contact with eyes; repeated exposure may cause cataract or glaucoma

• Long-term continuous use should be avoided, especially in children

Overdose Effects

Acute overdose is unlikely. Chronic overuse or misuse may cause features of hypercortisolism. In such cases, topical steroid therapy should be gradually discontinued.

Storage Conditions

Store below 30°C, protected from light and moisture. Do not freeze. Keep out of the reach of children.

Use in Special Populations

In infants and children under 12 years, long-term continuous therapy should be avoided due to the risk of adrenal suppression and skin atrophy.